Please login to the form below

Not currently logged in
Email:
Password:

cilengitide

This page shows the latest cilengitide news and features for those working in and with pharma, biotech and healthcare.

Glioblastomas - a personalised future?

Glioblastomas - a personalised future?

Another angiogenesis inhibitor, cilengitide, is in phase 3 development in Germany and the US in combination with temozolomide and radiation therapy, in newly diagnosed patients, and phase 2 in Germany in

Latest news

  • Merck KGaA forges clinical alliance with Quintiles Merck KGaA forges clinical alliance with Quintiles

    Moreover It has suffered a number of late-stage pipeline disappointments of late, including failures for brain and lung cancer prospect cilengitide and cladribine for multiple sclerosis.

  • Merck KGaA to meet 2014 financial targets one year early Merck KGaA to meet 2014 financial targets one year early

    and recently-licensed MS drug Tcelna (imilecleucel-T) following the decision to drop brain and lung cancer prospect cilengitide from development in the first quarter.

  • Late-stage failure for Merck’s cilengitide in brain cancer Late-stage failure for Merck’s cilengitide in brain cancer

    Merck KGaA has endured a pipeline setback with disappointing phase III results for its investigational brain cancer drug cilengitide. ... However, this has not proved the case for cilengitide in Merck's phase III CENTRIC (a) trial.

  • Cilengitide could promote tumour growth

    It was suggested that this could be a previously unknown characteristic of drugs similar to cilengitide. ... Results of the cilengitide study were published in the March 22 online issue of Nature Medicine.

  • Back on track

    Merck's Cilengitide has demonstrated promising results in a phase I trial and is currently undergoing phase II studies in the US. ... Cilengitide is a vitronectin (avï 3) inhibitor designed to inhibit angiogenesis.

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

How nature can help you manage the pressures of agency life
Paul Hutchings, founder of fox&cat, outlines how nature can help you can boost staff wellbeing in your agency this Mental Health Awareness Week...
How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....